Skip to content

Precigen PGEN Total debt

Total debt at other companies

Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$36.83M+59.4%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$35.75M-32.5%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
$8.05M-31.9%
Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
Gilead Sciences logo
Gilead SciencesGILD

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$1.91B+213%
Enterprise value$2B+234%
P/S72×

Profitability

See full
Gross margin83.6%
Operating margin-2,890.9%
Net margin-3,656%
FCF margin-1,756.5%

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×
Current ratio4.8×+1.3×

Where this comes from

Calculated from Precigen’s reported figures.

Plus components not separately reported this period.

The official record: Precigen’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Precigen's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Precigen's total debt?
Precigen (PGEN) reported total debt of $98.25M in Q1 2026.
How has Precigen's total debt changed year-over-year?
Precigen's total debt increased by 1713.7% year-over-year, from $5.42M to $98.25M.
What is the long-term trend for Precigen's total debt?
Over 5 years (2020 to 2025), Precigen's total debt has grown at a -11.6% compound annual growth rate (CAGR), from $182.28M to $98.29M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.